Check out how Exploristics can help get clinical trials back on track after disruption due to COVID-19
Unexpected disruption to clinical trials, such as that seen in the global COVID-19 pandemic, can have a devastating impact on patients and healthcare systems and cause numerous unforeseen challenges for developers of medicines, medical diagnostics and devices. At Exploristics, they offer a unique package of statistical expertise and tools to address issues arising from the current situation, helping healthcare and life sciences organisations overcome the challenge and getting trials back on track.
Pharma marketing is constantly changing and #AI is helping to reshape how brands connect with their audiences.
Discover Medico Digital top 5 #AI predictions and learn how harnessing the power of AI can boost your marketing strategy. Read more here.
Luscii provides the tools for patient and professional to keep an eye on the recovery while checking vital signs and symptoms to signal deteriorations and intervene timely in case of need.
Read more here.